Suneva Medical: FDA accepts label update for Suneva's Plasma IQ

Plasma IQ label, including the removal of the product's eye contraindication. The removal of this specific contraindication was due in part to a compilation of literature provided to the FDA showing the safety and efficacy of the ablative device on skin tissue, particularly around the eye area. This label update allows Suneva to address treatment [...] The post FDA accepts label update for Suneva's Plasma IQ appeared first on Medical Buyer.